Anticodon-engineered tRNAs restore full-length MeCP2 expression and function in Rett syndrome nonsense mutations - Poll - MDSpire

Anticodon-engineered tRNAs restore full-length MeCP2 expression and function in Rett syndrome nonsense mutations

  • By

  • Elena Fara

  • Stefano Pezzini

  • Ginevra Arpaia

  • Angelisa Frasca

  • Joseph J. Porter

  • John D. Lueck

  • Nicoletta Landsberger

  • June 1, 2026

  • 0 min

Share

Original Source(s)

Anticodon-engineered tRNAs restore full-length MeCP2 expression and function in Rett syndrome nonsense mutations

  • by Elena Fara, Stefano Pezzini, Ginevra Arpaia, Angelisa Frasca, Joseph J. Porter, John D. Lueck, Nicoletta Landsberger

  • June 1, 2026

Related Content

Disease outcomes with ublituximab in treatment-naïve participants: subpopulation analyses of the phase 3 ULTIMATE I and II studies in participants with relapsing multiple sclerosis

Advances in AI-based diagnosis of Alzheimer’s disease using MRI: a comprehensive survey

Ultrasound-guided hydrodissection of the subclavius muscle region in neurogenic thoracic outlet syndrome: a case report